Conclusions
The mechanisms of tolerance induction and its breakdown are important to explore because of its involvement in the pathogenesis of many known autoimmune diseases. Tolerance to “self” is not absolute and can be overcome by the immune system after a foreign stimuli caused by pathogens, allergens or other imknown immune errors (e.g., defects in apoptosis) that affect the immune system, causing a switch from tolerance to an immune response. Therefore, autoimmune diseases may often result from an aberrant or dysfunctional immune response that can no longer discriminate between “self” and “non self” proteins. This deregulation will eventually lead to a systemic disease manifested by organ or tissue specific disorder and pathogenesis. Reversal of this breakdown by the re-introduction of tolerance is therefore an important goal.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Woods JM, Katschke KJ, Volin MV et al. IL-4 Adenoviral gene therapy reduces inflammation, proinflammation cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J Immunol 2001; 166:1214–1222
Chang Y, Prud’homme GJ. Intramuscular administration of expression plasmids encoding interferon-g receptor/IgGl or IL-4/IgGl chimeric proteins protects from autoimmunity. J Gene Med 1999; 1:415–423.
Costa GL, Sandora MR, Nakajima A et al. Adoptive Immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12p40 subunit. J Immunol 2001; 167:2379–2387.
Takiguchi M, Murakami M, Nakagawa I et al. CTLA4-IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice. Life Sci 2000; 66:991–1001.
Quattrocchi E, Dallman MJ, Feldman M. Adenovirus-mediated gene transfer of CTLA4-Ig fusion protein in the suppression of experimental autoimmune arthritis. Arthritis Rheum 2000; 43:1688–1697.
Zambidis ET, Scott DW. Epitope-specific tolerance induction with an engineered immunoglobulin. Proc Nad Acad Sci USA 1996; 93:5019–5024.
Zambidis ET, Barth RK, Scott DW. Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients. J Immunol 1997; 158:2174–2182.
Zambidis ET, Kurup A, Scott DW. Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B-lymphocytes. Mol Med 1997; 3:212–224.
Kang Y, Melo M, Deng E et al. Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: The IgG scaffold is important for induction and maintenance of immune hyporesponsiveness. Proc Natl Acad Sci USA 1999; 96:8609–8614.
El-Amine M, Melo M, Scott DW. Gene therapy for tolerance and autoimmunity: Soon to be fulfilled promises? Clin Immunol 2001; 99:1–6.
Melo M, El-Amine M, Tonnetti L et al. Gene therapeutic approaches to induction and maintenance of tolerance. Int Rev Immunol 2001; 20:627–645.
Scott DW, Venkataraman M, Jandinski JJ. Multiple pathways of B-cell tolerance. Immunol Rev 1979; 43:241–273.
Venkataraman M, Scott DW. Cellular events in tolerance. VII. Decrease in clonable precursors stimulatable in vitro by specific antigens or LPS. Cell Immunol 1979; 47:323–331.
Aldo-Benson M, Borel Y. The tolerant cell: direct evidence for receptor blockade. J Immunol 1974; 112:1793–1803.
Venkataraman M, Aldo-Benson M, Borel Y et al. Persistence of antigen-binding cells with surface tolerogen: Isologous versus heterologous immunoglobulin carriers. J Immunol 1977; 119:1006–1009.
Min B, Legge LK, Caprio JC et al. Differential control of neonatal tolerance by antigen dose versus extended exposure and adjuvant. Cell Immunol 2000; 200:45–55.
Kang J, Wither J, Hozumi N. Long-term expression of a T-cell receptor beta-chain gene in mice reconstituted with retrovirus-infected hematopoietic stem cells. Proc Natl Acad Sci USA 1990; 87:9803–9807.
El-Amine M, Hinshaw JA, Scott DW. In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragment. Int Immunol 2002; 14:761–766.
Ravetch JV, Bolland S. IgG Fc receptors. Ann Rev Immunol 2001; 19:275–290.
El-Amine M, Melo M, Kang Y et al. Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells. J Immunol 2000; 165:5631–5636.
Krieg AM, Yi AK, Matson S et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374:546–549.
Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol 1997; 158:1989–1993.
Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995; 182:459–465.
Maraskovsky E, Brasel K, Teepe M et al. Dramatic increase in the numbers of functionally mature cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J Exp Med 1996; 184:1953–1962.
Pulendran B, Smith JL, Jenkins M et al. Prevention of pripheral tolerance by a dendritic cell growth factor: Flt3 ligand as an adjuvant. J Exp Med 1998; 188:2075–2082.
Pack CD, Cestra AE, Min B et al. Neonatal exposure to antigen primes the immune system to develop responses in various lymphoid organs and promotes bystander regulation of diverse T cell specificities. J Immunol 2001; 167:4187–95.
Agarwal RK, Kang Y, Zambidis E et al. Retroviral gene transfer of an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest 2000; 106:245–252.
Melo M, Qian J, El-Amine M et al. Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J Immunol 2002; 168:4788–4795.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2005 Eurekah.com and Kluwer Academic / Plenum Publishers
About this chapter
Cite this chapter
El-Amine, M., Litzinger, M., Melo, M.E.F., Scott, D.W. (2005). Gene Therapy-Based Approach for Immune Tolerance Induction Using Recombinant Immunoglobulin Carriers. In: Gene Therapy of Autoimmune Diseases. Medical Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/0-387-28670-5_6
Download citation
DOI: https://doi.org/10.1007/0-387-28670-5_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47991-5
Online ISBN: 978-0-387-28670-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)